NTLA Stock Price History and Quote Analysis Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own NTLA shares is 423, representing 88.12% of the company's common stock.

RUSSELL INVESTMENTS GROUP, LTD., in the last quarter, reduced its stake in NTLA by -0.86% restricting it's holding to 110.24 thousand shares of worth nearly $3.03M. LAZARD ASSET MANAGEMENT LLC also lessened -11.91% of the NTLA shares from its portfolio, reducing its holding to 90.06 thousand shares of worth $2.48M. SCHRODER INVESTMENT MANAGEMENT GROUP also shunned NTLA shares holding by -1.78% last quarter which brought its holding to 86.93 thousand shares worth $2.39M.

As per its latest 13F filing, WELLINGTON MANAGEMENT GROUP LLP increased its stake in NTLA by 69.4% in the last quarter. The institutional holder raised its holding to 4.16 million shares having worth more than $114.50M. STATE OF NEW JERSEY COMMON PENSION FUND D also added 23.86% more shares of NTLA to its portfolio, raising its holding to 100.8 thousand shares of worth $2.77M. INVESCO LTD. also increased its NTLA shares holding by 33.11% which brought its holding to 96.7 thousand shares worth $2.66M.

The insider with the most stakes in NTLA is N/A , N/A at the company. Additionally, NTLA stock is highly held by N/A N/A and N/A N/A among others.

Company executives, directors, and other insiders own 1.21% percent of Intellia Therapeutics, Inc.'s stock. Within the last six months, there have been 3 transaction(s) in which NTLA insiders have sold stock, totaling 3.92K shares. Insiders that have sold shares include DUBE MICHAEL P, CLARK ELIANA, and VERWIEL FRANK.

There have been 0 transaction(s) during the past 6-months in which Intellia Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 136.43K Intellia Therapeutics, Inc. shares are held by insiders, which represents about 1.21% of NTLA stock.

NTLA N/A, N/A holds the largest portfolio of the company's shares. NTLA shares owned by N/A total nearly -.

WELLINGTON MANAGEMENT GROUP LLP is the largest institutional owner in NTLA which holds 4.16 million shares worth $114.50M or 4.6% of the total NTLA shares outstanding followed by RUSSELL INVESTMENTS GROUP, LTD. with ownership of 110.24 thousand shares representing 0.12% of the NTLA ownership. STATE OF NEW JERSEY COMMON PENSION FUND D is the third largest stakeholder with 100.8 thousand shares or 0.11% of the ownership worth more than $2.77M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the NTLA is concerned, it is a stock which is optionable.

Number of NTLA shares short is 16.37M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 101.85M shares of NTLA are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, NTLA has 100.57M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for NTLA is 5.59.